Download PDF From to , children were born in Vila Nova Gaia , of which received BCG vaccine and 4 cases of BCGitis occurred in our. cases of BCGitis occurred in our center 3 were boys and none had cinated. There is no consensus about the management of BCGitis pnvpdf]. 3. Arch Pediatr. Jul;23(7) doi: /wfhm.info Epub Jun 2. [BCGitis/BCGosis in children: Diagnosis, classification and exploration].
|Language:||English, Dutch, Arabic|
|ePub File Size:||27.85 MB|
|PDF File Size:||16.33 MB|
|Distribution:||Free* [*Registration needed]|
However, although rare, systemic complications have been described.(1, 3 - 6) Systemic dissemination of the attenuated M. bovis bacillus is known as BCGitis. Pediatric Disseminated Bacillus Calmette-Guerin. Infection (BCGitis): A Case Report. Abdullah A. Alesa1, Hamed M. Aljiffry1, Khalid A. PDF | On 1, , I. Ladeira and others published BCGitis in children.
The patient underwent transurethral resection of the bladder tumor. Histological examination revealed urothelial cell carcinoma grade 2 , without vascular or muscle invasion.
Chemotherapy and immunotherapy with intravesical instillation of BCG were started and continued until December of In February of , the patient presented to the emergency department with a one-week history of dyspnea and productive cough mucopurulent sputum.
He reported no fever, chest pain, hemoptysis, sweating, or other symptoms.
Auscultation revealed bilateral breath sounds, with crackles in both lung bases. There were no other significant changes. In addition, a chest X-ray showed bilateral diffuse reticulonodular infiltrates.
BCGitis in a Patient with Transient Hypogammaglobulinemia of Infancy
A CT scan of the chest revealed randomly distributed micronodules in the lungs, together with enlargement of the hilar and mediastinal lymph nodes Figure 1. After having collected sputum for analysis, we started empirical antibiotic treatment with amoxicillin and clavulanic acid.
Due to respiratory failure and suspected miliary tuberculosis or diffuse pulmonary metastasis, the patient was admitted to the respiratory ward of the hospital.
During hospitalization, microbiological and mycobacteriological cultures of sputum samples were negative. Bronchoscopy revealed bilateral mucopurulent secretions, edema, and diffuse mucosal congestion.
Because of the positive result on the nucleic acid amplification test of the BALF, we started tuberculosis treatment with isoniazid, rifampin, pyrazinamide, and ethambutol. Despite improvements in his test results and clinical resolution of the respiratory failure, the patient showed a slight increase in liver enzymes to less than double the normal values. He underwent upper abdominal ultrasound, which revealed hepatic steatosis with no other abnormalities.
The patient was discharged and continued treatment on an outpatient basis. Future scheduled BCG instillations were suspended. In the initial phase of treatment, the regimen was the isoniazid-rifampin-ethambutol combination, whereas the isoniazid-rifampin combination was used in the maintenance phase.
After a total of 6 months of treatment, the patient showed a good response. At this writing, the patient remains under follow-up monitoring of his bladder, without signs of recurrence.
The patient gave written informed consent for the reporting of his case. After evaluation of the basic immunological functions, some of the patients were diagnosed with PID.
For these patients, the corresponding genes were detected according to their immune phenotype. Routine evaluation of immunological function The routine evaluation of immunological function involved the analysis of lymphocyte subsets; the detection of immunoglobulins G, A, M, E and complements C3, C4, and CH50; and the analysis of NADPH oxidase activity in neutrophils.
The respiratory burst of neutrophils was determined by measuring hydrogen peroxide production, using DHR analysis . We dispensed 4. Direct sequencing Based on the immune phenotype of these patients, the different genes were sequenced.
BCGitis: A rare complication after intravesical BCG therapy
The primer sequences were based on human genomic sequences and are available upon request. All of the entire coding regions were covered. Both strands were sequenced. These patients were all healthy at birth and had no contact history of TB.
All patients were vaccinated with BCG within two days after birth. Among these 74 children, 32 Clinical characteristics Age of onset. Among the 32 patients with definitive PID, 22 Among the 42 patients without definitive PID, the median age of onset is 4 months old range: 1 month to 2 years.
BCG disease classification. In the previous study  , BCG disease was classified as local, regional, distant, and disseminated. Local or regional BCG disease was diagnosed upon confirmation of M.
[BCGitis/BCGosis in children: Diagnosis, classification and exploration].
Among the 74 patients, the most common tissues and organs that were affected are lymph nodes, vaccination site, and lung, regardless of whether patients had PID or not Figure 1a. According to the above mentioned BCG disease classification, no case only had local infection, 39 Com- lymph nodes Fig.
A crust is formed around this induration, which is soft at the center for 3—4 weeks.
In children with follow-up imaging stud- tal guidelines and automatic exposure control. Pediatr Radiol — The most common side effects are local inflammation, fever, and pelvic adenopathy.